There’s been a terrific new wave of research and interest in the medical community recently of the potentially enormous health benefits of psychoactive substances.  A growing international call by prestigious research organizations and scientific publications for more investigation has helped to bring a much needed spotlight to this woefully underdeveloped field in order to unlock the massive scientific breakthroughs that psychoactive compounds hold.  Experts now believe that potential treatments and cures for Alzheimer’s, Parkinson’s, schizophrenia, addiction, and many more disorders lie within this type of research.  One researcher leading the pack is Dr. Stephen Ross, director of the NYU Addiction Psychiatry Fellowship, whose team is embarking on a fascinating new study exploring how the hallucinogenic compound, psilocybin, might help those with alcoholism.  You can watch his recent interview with CBS News above.  For more insight into the nature of addiction and the human brain be sure to watch the Charlie Rose special below.  And Terrence McKenna has a few words of wisdom to share about the matter as well.

SEE ALSO: Acclaimed Neuroscientist And Author Sam Harris Explores “Drugs And The Meaning Of Life”
SEE ALSO: The End Of Prozac Nation: Why Psychobiotics Are The Brilliant Future Of Psychiatry
SEE ALSO: Fascinating Psychopharmacology Research Indicates The Cure For Alcoholism Is Inside LSD
SEE ALSO: John Hopkins University Study Proves Treatment With LSD & Magic Mushrooms Keeps People Out Of Prison
SEE ALSO: The Incredible History Of The Santa Claus Myth: From Prostitution To Magic Arctic Mushrooms

.

Share.

Writer, editor, and founder of FEELguide. I have written over 5,000 articles covering many topics including: travel, design, movies, music, politics, psychology, neuroscience, business, religion and spirituality, philosophy, pop culture, the universe, and so much more. I also work as an illustrator and set designer in the movie industry, and you can see all of my drawings at http://www.unifiedfeel.com.

Comments are closed.

Exit mobile version